StarSEQ
StarSEQ GmbH is a Mainz-based German sequencing service provider offering in-house Sanger and Illumina NGS, bioinformatics, genotyping, and environmental DNA analysis to academic, pharmaceutical, and research customers across 40 countries, with full German data sovereignty.
- Company typePrivate
- Founded2008
- HeadquartersMainz, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What StarSEQ does
StarSEQ GmbH is a privately held German biotechnology service provider founded in 2008 as a spin-off of GENterprise Genomics and headquartered in Mainz on the campus of Johannes Gutenberg University. The company operates a single in-house laboratory that delivers Sanger sequencing (Applied Biosystems 3730), Next Generation Sequencing on Illumina MiSeq, NextSeq 2000, and NovaSeq platforms, plus complementary DNA/RNA extraction, PCR/RT-PCR, genotyping, fragment analysis, and microsatellite marker development. It also runs an Environmental DNA (eDNA) service line for biodiversity monitoring, supported by a proprietary curated reference database covering approximately 130 fish, 30 amphibian/reptile, 49 bird, and 48 mammal species. All wet-lab processing and bioinformatics are performed in Mainz under German/EU data jurisdiction, with no outsourcing to third parties, which the company positions as a data-sovereignty differentiator for European academic and pharmaceutical customers.
The company generates revenue primarily through per-sample and per-run transactional pricing across its service catalogue, supplemented by 12-month prepaid voucher packages (Sanger U-mix and V-mix tiers) that lock in budget commitment and provide volume discounts, plus add-on bioinformatics analysis and customized contract research. Go-to-market is hybrid: a self-serve e-commerce front end for standard Sanger and NGS orders alongside consultative sales for complex, custom, or high-value projects. Customers include academic institutions, pharmaceutical and chemical companies, veterinary diagnostic firms, food safety laboratories, and environmental monitoring agencies in 40 countries, with deeper collaborative ties to Universitätsmedizin Mainz, TRON gGmbH, and several BMBF/BMEL-funded consortia in glioblastoma, microbiome, food authentication, and ecotoxicology. The company is led by managing director Dr. Sven-Ernö Bikar, employs between 1 and 10 people, has not disclosed external funding rounds, and operates as a cash-flow-funded boutique rather than a venture-backed scale-up.
StarSEQ firmographics
Firmographics- Name
- StarSEQ
- Legal name
- StarSEQ GmbH
- Website
- https://starseq.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- StarSEQ GmbH is a Mainz-based German sequencing service provider offering in-house Sanger and Illumina NGS, bioinformatics, genotyping, and environmental DNA analysis to academic, pharmaceutical, and research customers across 40 countries, with full German data sovereignty.
- Ownership category
- akta.pro rank
StarSEQ industry classification
Industry- Product category
- Genomics and DNA Sequencing Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industry
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
Keywords
Where StarSEQ is headquartered
LocationHeadquarters
- HQ city
- Mainz
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
StarSEQ business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Sequencing Services: Per-sample and per-run pricing for Sanger sequencing, Next Generation Sequencing (NGS), and specialty sequencing services. Revenue generated through one-time payments per sample or run, with volume discounts available for larger batch orders.
- Prepaid Packages: Prepaid voucher packages for Sanger sequencing (U-mix and V-mix) offering volume-based pricing with significant per-sample discounts. Vouchers valid for 12 months.
- Bioinformatics Services: Additional bioinformatics analysis services including RNA-Seq alignment, differential expression analysis, genome assembly, annotation, and microbiome data analysis available as add-on services to core sequencing.
- DNA/RNA Preparation: Extraction and preparation services from various sample types including tissue, blood, stool, plant material, environmental samples, and food products.
- Contract Research: Customized research projects for specific client needs in genotyping, DNA testing, expression analysis, assay development, and specialized applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Sanger Sequencing U-mix: Customer mixes DNA and primer, StarSEQ handles sequencing |
| Unit Pricing | Pay-as-you-go | Sanger Sequencing V-mix: StarSEQ handles DNA/primer mixing and sequencing |
| Unit Pricing | Pay-as-you-go | Microbiome Analysis (16S/ITS/18S) - Single Step |
| Unit Pricing | Pay-as-you-go | RNA Sequencing - High Throughput Gene Expression (Promotion 1) |
| Unit Pricing | Pay-as-you-go | RNA Sequencing - Library + Sequencing + Bioinformatics (Promotion 2) |
| Unit Pricing | Pay-as-you-go | Bacterial Genome Sequencing - 100x coverage |
| Unit Pricing | Pay-as-you-go | Shotgun Metagenomic Sequencing |
| Unit Pricing | Pay-as-you-go | DNA/RNA Preparation Service |
| Unit Pricing | Pay-as-you-go | DNA Sequencing (Promotion) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
StarSEQ product offering
Product offeringCore offering
StarSEQ delivers contract DNA and RNA sequencing services (Sanger and Next Generation Sequencing on Illumina platforms) together with full in-house bioinformatics analysis, including genome assembly, variant detection, differential gene expression, microbiome/metagenomic classification, and environmental DNA metabarcoding. All wet-lab work, quality control, and data processing are performed exclusively at the Mainz laboratory, with sample shipment handled directly by clients globally in 40 countries.
Product overview
StarSEQ is a German biotechnology company offering a comprehensive portfolio of genetic analysis services centered around Sanger sequencing and Next Generation Sequencing (NGS) technologies. The core product suite includes Sanger Sequencing (U-mix and V-mix services), comprehensive NGS services (DNA/RNA sequencing, microbiome analysis, metagenomics, bacterial genome sequencing), bioinformatics analysis, genotyping services, fragment analysis, microsatellite marker development, PCR/RT-PCR services, DNA/RNA preparation, and environmental DNA (eDNA) services for biodiversity monitoring. The company operates exclusively in-house at its Mainz, Germany laboratory and also conducts research projects including microbAIome, GlioTraceGenOmics, OmicsGlioma, BIOCHANCEPLUS CHIROCHIP, MARINEFOOD, and the German Human Genome Project. StarSEQ was founded in 2008 as a spin-off of GENterprise Genomics, which it acquired in 2014, integrating that company's portfolio of molecular biology and biotechnology services.
Differentiator
Problem solved
Functional benefit
Products and services
- Sanger Sequencing Capillary DNA sequencing service on the ABI 3730 DNA Analyzer offered in U-mix (customer provides DNA and primer) and V-mix (StarSEQ performs mixing) formats for academic, pharmaceutical, and contract research customers worldwide.
- Next Generation Sequencing (NGS) Comprehensive NGS services on Illumina MiSeq, NextSeq 2000, and NovaSeq platforms, covering DNA sequencing, RNA sequencing, microbiome/metagenome analysis, bacterial whole genome sequencing, and SARS-CoV-2 genome sequencing for research institutions and pharma customers.
- Bioinformatics Analysis Bioinformatics services including de novo genome/transcriptome assembly, variant detection (SNPs, indels, CNVs, structural variants), gene expression and differential expression analysis (STAR, DRAGEN, DESeq2), and microbiome/metagenome classification (Kraken2, QIIME 2).
- Genotyping Services High-throughput mouse and rat genotyping covering DNA extraction, single and multiplex PCR, restriction enzyme digestion, RT-PCR, and SNP/Indel sequencing with QIAxcel and 3730 DNA Analyzer systems, primarily for animal research and breeding programs.
- Fragment Analysis Fragment length analysis on the ABI 3730 with ready-to-load and ready-to-mix options, supporting DS-30 and DS-33 dye sets for assay development and validation in life science and diagnostic contexts.
- Microsatellite Marker Development NGS-based microsatellite (SSR) marker development service including gDNA preparation, marker identification, PCR assay development, and fragment length analysis for agro sciences, ecology, and breeding applications.
- PCR and RT-PCR Service Broad-spectrum PCR services including standard PCR, real-time qPCR, and multiplex PCR with high and low throughput options, using Applied Biosystems and Biometra cyclers for research and diagnostic assay support.
- DNA/RNA Preparation DNA and RNA extraction service from diverse sample types including tissues, blood, stool, saliva, swabs, plants, fungi, bacteria, soil, water, food, and FFPE-preserved material, using automated Maxwell and Biomek systems.
- Environmental DNA (eDNA) Services Biodiversity monitoring services based on environmental DNA, including eDNA metabarcoding for Pisces, Amphibia, Aves, and Mammalia using proprietary curated databases, metagenomic snapshot sequencing, and species-specific qPCR detection for decapoda, pisces, and amphibia.
- Contract Research Customized contract research services for life science industries and academic institutions covering genotyping, DNA testing, expression analysis, assay development, transcriptome analysis, whole genome analysis, metagenomics, food testing, and disease panels.
Quantifiable outcome
- Read lengths over 1100 bp possible for Sanger sequencing
- +2 more outcomes
Companies that use StarSEQ
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles2 records
StarSEQ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
StarSEQ partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- curATime (Clusters4Future)corePart of the German Federal Ministry of Education and Research 'Clusters4Future' initiative promoting geographically concentrated partnership structures between stakeholders in a region. StarSEQ participates in the microbAIome project investigating host-microbiome interactions in atherothrombosis using microbiome-regulated enzymes and products of sphingolipid metabolism as diagnostic markers.
- TRON gGmbHcoreTranslational Oncology research organization at the Johannes Gutenberg University Mainz pursuing new diagnostics and drugs for cancer treatment. Focus on developing novel platforms for individualized therapies and biomarkers. StarSEQ collaborates on glioblastoma research projects including GlioTraceGenOmics and OmicsGlioma.
- bio.logis Center for Human GeneticsminorClinical institution with board-certified physicians for human genetics providing complete spectrum of genetic diagnostics and counselling. Located at Frankfurt Innovation Center for Biotechnology. bio.logis provides human diagnostic and personal genomics services to healthy clients, patients, and physicians using StarSEQ sequencing capabilities.
- mfd DiagnosticsminorVeterinary diagnostic company specialized in health monitoring, cryopreservation, rederivation, animal husbandry and breeding, immunization, and contract research on small rodents and pigs. Founded 2004 out of University of Mainz. GLP certified since 2006 and ISO 9001 certified since 2010. Partner for animal healthcare and veterinary diagnostic services.
- Universitätsmedizin Mainz (University Medical Center Mainz)coreFifth largest university in Germany, only University Medical Center in Rhineland-Palatinate. Provides healthcare to highest university standard while conducting cutting-edge medical research. Collaborates with StarSEQ on SARS-CoV-2 Sequencing Consortium Mainz for variant surveillance and glioblastoma research projects.
- Galantos GeneticsminorSpecialized laboratory for validated genetic testing and DNA preparation from forensic samples or swabs. Run by academics providing quality service and genetic testing with new improved forms of genetic and forensic tests. Accredited by European Standards (ISO 17025) by DAkkS. Partner for validated genetic testing services.
- Mainzer Wissenschaftsallianz (Mainz Science Alliance)minorNon-profit association representing research and technological know-how in Mainz region since 2008. Founded 2013 to increase networking of universities, scientific institutions, and companies. Objective is to promote research and science and strengthen Mainz as a centre of scientific activity.
- SARS-CoV-2 Sequencing Konsortium MainzcoreConsortium including Universitätsmedizin Mainz, Johannes Gutenberg Universität, and StarSEQ providing technological platform for SARS-CoV-2 genome sequencing according to Robert Koch Institute guidelines. Sequences uploaded to RKI and GISAID Initiative for national surveillance. Partners include Institute of Virology, Institute of Human Genetics, Hospital Hygiene, Transfusion Center, Coronavirus Test Center, and Molecular Genetics department.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
StarSEQ competitors and assessment
Company assessmentBroad incumbents
- BGI Genomics: One of the largest global DNA sequencing service providers with extensive DNBSEQ platform investment. Competes broadly with StarSEQ on NGS pricing, and is the type of "state-influenced / subsidy-driven Asian provider" StarSEQ explicitly differentiates against.
- GENEWIZ (Azenta Life Sciences): Global genomics services provider (now part of Azenta) offering Sanger, NGS, and synthetic biology services across the US, Europe, and Asia. Direct competitor on Sanger and NGS service pricing, with significantly larger operational scale.
- Illumina (Sequencing Services): Dominant NGS platform vendor that also operates direct sequencing services using its own instruments. Competes with StarSEQ at the project level (especially NovaSeq-class jobs) and controls the supply of reagents, flow cells, and instruments that StarSEQ depends on for its NGS pipeline.
- QIAGEN (Genomics Services): Global life sciences tools and services company with a genomics services arm offering next-generation sequencing, bioinformatics, and sample-preparation services. Competes with StarSEQ on bioinformatics, NGS, and sample-preparation workflows for pharma and academic customers.
- Eurofins Genomics: One of the world's largest commercial genomics service providers, offering Sanger sequencing, NGS, oligonucleotides, and bioinformatics across Europe, the US, and Asia. Directly competes with StarSEQ's Sanger and NGS service catalog but at much larger scale and broader geographic reach.
- Novogene: China-based global sequencing services company offering NGS, Sanger, and bioinformatics with large-scale Illumina platforms. Competes with StarSEQ on NGS projects for European academic and pharma customers, typically at lower price points.
- LGC Biosearch Technologies (LGC Genomics): European-headquartered genomics services and reagents provider (formerly LGC Genomics) offering Sanger, NGS, and genotyping services globally. Competes directly with StarSEQ on Sanger and genotyping, with broader catalog and larger installed reagent base.
Direct peers
- Atlas Biolabs: Berlin-based genomics services company offering SNP genotyping, NGS, and contract research for academic and clinical customers. Directly comparable German peer with overlapping genotyping and NGS service catalog at similar mid-market positioning.
- CeGaT: German sequencing and bioinformatics services company based in Tübingen, offering Sanger, NGS, and clinical exome/genome interpretation. Closest German peer to StarSEQ with overlapping service lines and similar "Made in Germany" positioning, but with broader clinical interpretation capabilities.
- Macrogen: Korean-headquartered global sequencing services provider offering Sanger, NGS, and bioinformatics to academic and pharma clients in 40+ countries. Head-to-head competitor on Sanger pricing and NGS service catalogs, with StarSEQ explicitly positioning its "no Asia affiliations" stance against providers like Macrogen.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
StarSEQ social profiles
Digital presenceStarSEQ compliance and trust
Trust signalCompliance1 record
StarSEQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
StarSEQ leadership team
Management profileNumber of profiles
Profiles1 record
StarSEQ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
StarSEQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about StarSEQ
What does StarSEQ do?
StarSEQ delivers contract DNA and RNA sequencing services (Sanger and Next Generation Sequencing on Illumina platforms) together with full in-house bioinformatics analysis, including genome assembly, variant detection, differential gene expression, microbiome/metagenomic classification, and environmental DNA metabarcoding. All wet-lab work, quality control, and data processing are performed exclusively at the Mainz laboratory, with sample shipment handled directly by clients globally in 40 countries.
Is StarSEQ a public or private company?
StarSEQ is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was StarSEQ founded?
StarSEQ was founded in 2008. It employs 1 to 10 people.
Where is StarSEQ based?
StarSEQ is headquartered in Mainz, Germany, in the Europe region.
How does StarSEQ make money?
Five revenue lines are on record. Sequencing Services are the primary driver. The others are prepaid Packages, bioinformatics Services, DNA/RNA Preparation and contract Research.
Who are StarSEQ's main competitors?
Broad incumbents on record are BGI Genomics, GENEWIZ (Azenta Life Sciences), Illumina (Sequencing Services), QIAGEN (Genomics Services), Eurofins Genomics, Novogene and LGC Biosearch Technologies (LGC Genomics). Direct peers are Atlas Biolabs, CeGaT and Macrogen.
Does StarSEQ have an API?
No public API is recorded for StarSEQ.
What industry is StarSEQ in?
StarSEQ's product category is Genomics and DNA Sequencing Services. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 541714 and its SIC code is 8731.